Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01079598 · ClinicalTrials.gov registry record · NA
RFS (Radiofrequency Stylet) - Radiofrequency Perforator Vein Treatment Study
A NA study, sponsored by Medtronic Endovascular.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01079598: Clinical Trial NA study, sponsored by Medtronic Endovascular.
NCT01079598 is a NA study that was terminated before completion, run by Medtronic Endovascular. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01079598, a NA study, was terminated before completion, sponsored by Medtronic Endovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that patients will improve the immediate treatment outcomes from successive radiofrequency ablation (RFA) of incompetent perforator veins (IPVs).
Primary Outcome
QOL and clinical assessments measured by periodic CIVIQ2 and VCSS assessments were planned to be compared at each follow-up visit to pretreatment baseline. However, with the very low enrollment and limited data available, analysis and study results are inconclusive.
Interventions
- DEVICE RF Ablation (ClosureRFS Stylet)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-01 |
| Phase | NA |
Why NCT01079598 stopped before completion
NCT01079598 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which RF Ablation (ClosureRFS Stylet) is the first listed.
NCT01079598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01079598 about?
NCT01079598 is a clinical study titled "RFS (Radiofrequency Stylet) - Radiofrequency Perforator Vein Treatment Study". The purpose of this study is to demonstrate that patients will improve the immediate treatment outcomes from successive radiofrequency ablation (RFA) of incompetent perforator veins (IPVs).
What is the current status of trial NCT01079598?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2010-03. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01079598?
The interventions under investigation include: RF Ablation (ClosureRFS Stylet) (DEVICE).
Who is sponsoring clinical trial NCT01079598?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01079598's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia